Latest pharma feed

Industry events

Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity

ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 2...

Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)

REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk...

Cantor Global Healthcare Conference 2025

2025 Jefferies Global Healthcare Conference

Leerink Global Healthcare Conference

Generic Drug User Fee Amendments

This page features news and information for industry and stakeholders about GDUFA, its fee structure...

What’s New for Biologics

Latest news from the Center for Biologics Evaluation and Research

Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Refere...

Decision: Medical devices given exceptional use authorisations

List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes...

What's New Related to Drugs

Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety...

Clinical trials for medicines: guidance on quality and risk proportionality

Information on applying quality by design, risk‑based quality management, and proportionate oversigh...

Clinical trials for medicines: guidance on compliance with ICH E6 good clinical practice (GCP) in the United Kingdom

Information on how ICH E6(R3) good clinical practice (GCP) principles are implemented and enforced i...

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

Data highlights efficacy and safety of risankizumab in psoriatic disease, including high impact area...

Resource Capacity Planning and Modernized Time Reporting

FDA is making optimal use of its financial resources to maximize its ability to efficiently and effe...

Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis

Screening Programme detects thousands of lung cancers early with potential to save lives

The programme uses low-dose computed tomography (LDCT) scans to identify lung cancer at an earlier,...

27 March 2026Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis BSubmission supported by statistically significant and clinically meaningful functional cure rates in pivotal PhIII B-Well trials

‘Milestone’ research method measures gene activity across whole mice

Bullous haemorrhagic cellulitis caused by Escherichia coli in a patient with cirrhosis

Double-dose azithromycin mass drug administration, facial cleanliness, and fly control measures for trachoma control in Oromia, Ethiopia (Stronger SAFE): a cluster-randomised controlled trial

Ethical Design and Implementation of Monetary Transfer Interventions in Clinical Cancer Research

Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response

Press releaseMar 27, 2026Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases - Lead asset Exl-111 builds on proven IgE biology with a differentiated…

- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven...

Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)

The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summ...

[ANZEN]PMDA Risk Communications: Infliximab (genetical recombination) etc. posted

医薬品・医療機器・再生医療等製品の承認審査・安全対策・健康被害救済の3つの業務を行う組織。

[SHINSA]Document-based Inspection to CTD M3(Quality studies)/M4(Non-clinical studies other than GLP studies) data page created

医薬品・医療機器・再生医療等製品の承認審査・安全対策・健康被害救済の3つの業務を行う組織。

These small African antelopes may help mpox spread

Agenda for April 2026 Cancer Treatments advisory committee (CTAC) meeting

Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcom...

New treatment for relapsed extensive-stage small cell lung cancer

Imdylltra addresses unmet need in people with poor prognosis and limited treatment options

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2026

Five new medicines recommended for approval; another 13 medicines recommended for extension of their...

EMA recommends restricting use of Tecovirimat SIGA

The medicine was not effective for the treatment of mpox in randomised clinical trials

AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study

Risk assessment of secondary primary malignancies: results from two large prospective European cohorts

A comprehensive foundation model for generalizable cytogenetics in precision oncology with CHROMA

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic ob...

2026 03 27 12 00 00 3263711

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU appr...

Notice Regarding Bridge Loan Financing in Connection with an Additional Investment in ViiV Healthcare Ltd

Spectrum News 1: Cedars-Sinai Researchers Create New AI-Based System to Read Echocardiograms

Cedars-Sinai cardiologist David Ouyang told Spectrum News 1 about a new AI tool that can read echoca...

Bioprocess Online Covers Novo Nordisk Feature at the 2026 ISPE Facilities of the Future Conference

During a sustainability panel at the 2026 ISPE Facilities of the Future Conference, Larry Lane and J...

An Open Letter to the Pompe and Fabry Communities

Learn more about BioMarin's origin story and longstanding commitment to rare diseases in this open l...

View latest results

公告115年度「國家藥物科技研究發展獎」自公告日起至115年6月30日止受理申請。

公告115年度「國家藥物科技研究發展獎」自公告日起至115年6月30日止受理申請。

Medicine deliveries continue despite the conflict in the Middle East3/27/2026 Orion Pharma and Society

Global supply chains have remained resilient despite the escalating conflict in the Middle East. Whi...

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the disc...

27 MAR 2026PharmaceuticalsOtsuka Pharmaceutical to Acquire Transcend Therapeutics - Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend’s portfolio, including the TSND-201 program for post-traumatic stress disorder (PTSD)

Otsuka Pharmaceutical Co., Ltd News Releases

27 MAR 2026PharmaceuticalsOtsuka Submits Application in Japan for Iclusig®for First-Line Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Otsuka Pharmaceutical Co., Ltd News Releases

PharmaMed 2026 का समापन

Press Information Bureau (PIB) is the nodal agency of the Government of India to disseminate informa...

Feature Stories

Zoetis is a global animal health company dedicated to supporting customers and their businesses in e...

27.03.2026 [PM 007/26]Mehr Frauenerwerbstätigkeit stärkt Arbeitsmarkt und WachstumDeutschland ist so fleißig wie nieMehr Frauenerwerbstätigkeit stärkt FachkräftebasisTeilzeit, weibliche Führungskräfte und Vergütung sind...

Mehr Frauenerwerbstätigkeit stärkt Arbeitsmarkt und Wachstum Mehr Frauenerwerbstätigkeit stärkt Fach...

Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years

Irish Statutory Financial Statements

Investors - Financials & Filings - Irish Statutory Financial Statements | Prothena Corporation plc

20260327 Whc Reg

Gedeon Richter Investors Announcements Richter receives European Commission approval for FYLREVY® (E...

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first...

Over-The-Counter Monograph Drug User Fee Program (OMUFA)

A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potentia...

Guidance: Archiving and retention of clinical trial records

Information on clinical trial record retention and archiving requirements including requirements for...

Clinical trials for medicines: good manufacturing practice and radiopharmaceutical investigational medicinal products

Guidance on good manufacturing practice and the use of radiopharmaceutical investigational medicinal...

Accelerated assessment procedures support the conduct of drug trials in Estonia and Europe

The State Agency of Medicines has established a national accelerated assessment procedure and is als...

Transparency data: MHRA Performance Data

Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline...

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. Reply

Sacituzumab Govitecan in Advanced Triple-Negative Breast Cancer. Reply

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3. Reply

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

New WHO recommendations for tuberculosis diagnosis

Methodological quality assessment tool for observational studies comparing treatment effectiveness in infectious diseases: a Delphi consensus and application to studies on bloodstream infections due to carbapenem-resistant Enterobacterales

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Old Dog, New Tricks: Oxybutynin for the Treatment of Androgen Deprivation Therapy-Related Vasomotor Symptoms

Targeting enhancer RNAs to silence transcription

Benchmarking clonal hematopoiesis in sickle cell disease

Mandato E, Yan Q, Ouyang J, et al. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an Interaction with DOCK8. Blood. 2023;142(14):1219-1232

The Lundbeck Foundation Annual Report 2025

In 2025, the Lundbeck Foundation delivered strong financial results and maintained a high level of g...

OMNIPAQUE 300 mg, OMNIPAQUE 350 mg Iodo /ml SOLUCION INYECTABLE y VISIPAQUE 320 mg /ml SOLUCION INYECTABLE

Formato pdf Fecha de publicación: 26 de marzo de 2026 Nº alerta: R_16/2026 Fecha: 25 de marzo de 202...

La AEMPS informa de la detección de un lote falsificado de cánulas nasales con conexión luer-lock para adultos

Generar PDF Fecha de publicación: 26 de marzo de 2026 Categoría: productos sanitarios, productos fal...

Galapagos Announces Nomination of Gino Santini to its Board of Directors

Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings

Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)

- Five scientific e-posters highlight investigational neurotoxin trenibotulinumtoxinE (TrenibotE), d...

Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco

Research reveals an industry mindset shift towards 'undetectable†' aesthetics, as people seek a natu...

Innate Pharma reports full year 2025 financial results and business update

Lacutamab TELLOMAK-3 confirmatory Phase 3 trial in cutaneous T-cell lymphoma (CTCL) is planned for i...

„Medikamente Info Austria“ liefert kompakte Medikamenten-Information im neuen Design

Mit 10. Februar 2026 beginnt der Echtbetrieb für das neue Medikamenten-Informationssystem des Bundes...

World report on promoting the health of refugees and migrants: Monitoring progress on the WHO global...

The report calls for stronger leadership, sustained investment and enhanced coordination to promote...

Investor Highlights.Html

Here you will get an overview of all the information and services that we provide for you as a Novo...

Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program

Financial Highlights

Takeda provides annual and quarterly financial highlights, statements, and data for investors. Data...

Statements & press releases26.03.26PFAS restrictions: risks for patients and companies operating in EuropeRead Article

EFPIA reaction to the publication of ECHA scientific committees’ opinions on PFAS Restriction. The p...

Finnegan Receives Gold Level Healthy Workforce Designation and Bicycle Friendly Business Award

26.03.2026 [PM 006/26]Daten als Standortfaktor: EHDS stärkt Europas Forschung und InnovationEHDS schafft größten vernetzten Datenraum für Gesundheitsdaten weltweitMehr Dynamik in klinischer Forschung und InnovationNationale Umsetzung...

Daten als Standortfaktor: EHDS stärkt Europas Forschung und Innovation EHDS schafft größten vernetzt...

Financial Reports - 2025

Financial Reports Financial Reports - 2026 Financial Reports - 2025 Financial Reports - 2024 Financi...

Mar.26.2026R & DOno Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan

Application submitted for manufacturing and marketing approval of ripretinib in Japan for the indica...

Mar 26, 2026Internal3HTA Monthly Wrap - March 2026The latest in NZ healthtech, including upcoming events, sector news and insightsRead more

The latest in NZ healthtech, including upcoming events, sector news and insights

AAD 2026: Almirall presents new clinical and real‑world evidence across atopic dermatitis, psoriasis, actinic keratosis and acne

Almirall advances scientific leadership in medical dermatology with new data across atopic dermatiti...

Regulatory Education for Industry (REdI) Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products - 05/19/2026

Learn directly from the FDA’s regulatory experts in medical product centers: drugs, devices, and bio...

Guidance: Medicines that you cannot export from the UK or hoard

Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK pat...

Workshops, Meetings & Conferences (Biologics)

Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biol...

Shaping the Future of Healthcare Through Global Regulatory Innovation

Emerging technologies like AI and advanced therapies are transforming healthcare, and through intern...

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome

The U.S. Food and Drug Administration approved Avlayah (tividenofusp alfa-eknm) to treat certain ind...

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic ob...

2026 03 27 12 00 00 3263711

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU appr...

Notice Regarding Bridge Loan Financing in Connection with an Additional Investment in ViiV Healthcare Ltd

Spectrum News 1: Cedars-Sinai Researchers Create New AI-Based System to Read Echocardiograms

Cedars-Sinai cardiologist David Ouyang told Spectrum News 1 about a new AI tool that can read echoca...

Bioprocess Online Covers Novo Nordisk Feature at the 2026 ISPE Facilities of the Future Conference

During a sustainability panel at the 2026 ISPE Facilities of the Future Conference, Larry Lane and J...

An Open Letter to the Pompe and Fabry Communities

Learn more about BioMarin's origin story and longstanding commitment to rare diseases in this open l...

View latest results

公告115年度「國家藥物科技研究發展獎」自公告日起至115年6月30日止受理申請。

公告115年度「國家藥物科技研究發展獎」自公告日起至115年6月30日止受理申請。

Medicine deliveries continue despite the conflict in the Middle East3/27/2026 Orion Pharma and Society

Global supply chains have remained resilient despite the escalating conflict in the Middle East. Whi...

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the disc...

27 MAR 2026PharmaceuticalsOtsuka Pharmaceutical to Acquire Transcend Therapeutics - Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend’s portfolio, including the TSND-201 program for post-traumatic stress disorder (PTSD)

Otsuka Pharmaceutical Co., Ltd News Releases

27 MAR 2026PharmaceuticalsOtsuka Submits Application in Japan for Iclusig®for First-Line Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Otsuka Pharmaceutical Co., Ltd News Releases

PharmaMed 2026 का समापन

Press Information Bureau (PIB) is the nodal agency of the Government of India to disseminate informa...

Feature Stories

Zoetis is a global animal health company dedicated to supporting customers and their businesses in e...

27.03.2026 [PM 007/26]Mehr Frauenerwerbstätigkeit stärkt Arbeitsmarkt und WachstumDeutschland ist so fleißig wie nieMehr Frauenerwerbstätigkeit stärkt FachkräftebasisTeilzeit, weibliche Führungskräfte und Vergütung sind...

Mehr Frauenerwerbstätigkeit stärkt Arbeitsmarkt und Wachstum Mehr Frauenerwerbstätigkeit stärkt Fach...

Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years

Irish Statutory Financial Statements

Investors - Financials & Filings - Irish Statutory Financial Statements | Prothena Corporation plc

20260327 Whc Reg

Gedeon Richter Investors Announcements Richter receives European Commission approval for FYLREVY® (E...

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first...

Over-The-Counter Monograph Drug User Fee Program (OMUFA)

A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potentia...

Guidance: Archiving and retention of clinical trial records

Information on clinical trial record retention and archiving requirements including requirements for...

Clinical trials for medicines: good manufacturing practice and radiopharmaceutical investigational medicinal products

Guidance on good manufacturing practice and the use of radiopharmaceutical investigational medicinal...

Accelerated assessment procedures support the conduct of drug trials in Estonia and Europe

The State Agency of Medicines has established a national accelerated assessment procedure and is als...

Transparency data: MHRA Performance Data

Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline...

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. Reply

Sacituzumab Govitecan in Advanced Triple-Negative Breast Cancer. Reply

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3. Reply

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

New WHO recommendations for tuberculosis diagnosis

Methodological quality assessment tool for observational studies comparing treatment effectiveness in infectious diseases: a Delphi consensus and application to studies on bloodstream infections due to carbapenem-resistant Enterobacterales

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Old Dog, New Tricks: Oxybutynin for the Treatment of Androgen Deprivation Therapy-Related Vasomotor Symptoms

Targeting enhancer RNAs to silence transcription

Benchmarking clonal hematopoiesis in sickle cell disease

Mandato E, Yan Q, Ouyang J, et al. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an Interaction with DOCK8. Blood. 2023;142(14):1219-1232

The Lundbeck Foundation Annual Report 2025

In 2025, the Lundbeck Foundation delivered strong financial results and maintained a high level of g...

OMNIPAQUE 300 mg, OMNIPAQUE 350 mg Iodo /ml SOLUCION INYECTABLE y VISIPAQUE 320 mg /ml SOLUCION INYECTABLE

Formato pdf Fecha de publicación: 26 de marzo de 2026 Nº alerta: R_16/2026 Fecha: 25 de marzo de 202...

La AEMPS informa de la detección de un lote falsificado de cánulas nasales con conexión luer-lock para adultos

Generar PDF Fecha de publicación: 26 de marzo de 2026 Categoría: productos sanitarios, productos fal...

Galapagos Announces Nomination of Gino Santini to its Board of Directors

Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings